ALFWQ yields 1000000.00% · JNJ yields 2.13%● Live data
📍 ALFWQ pulled ahead of the other in Year 1
Combined, ALFWQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALFWQ + JNJ for your $10,000?
Alfi, Inc. provides Software as a Service (SaaS) solution for the digital out of home (DOOH) smart advertising segment in the United States. It offers Alfi, an artificial intelligence (AI) SaaS platform that transforms DOOH advertising into real-time audience-based marketing, as well as uses AI and computer vision to detect audience demographics, such as age and gender to serve relevant advertising. The company intends to market Alfi to advertisers, and other DOOH and out of home media operators as the first facial detection-based ad technology offering verified impressions and audience measurement based on eyes on screens. The company was formerly known as Lectrefy, Inc. and changed its name to Alfi, Inc. in January 2020. Alfi, Inc. was founded in 2018 and is based in Miami Beach, Florida. On October 14, 2022, Alfi, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Full ALFWQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.